INTELLIGENT BIO SOLUTIONS INC. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent Warrant Agency Agreement Dated as of ______, 2023 WARRANT AGENCY AGREEMENTWarrant Agency Agreement • September 22nd, 2023 • Intelligent Bio Solutions Inc. • Surgical & medical instruments & apparatus • New York
WARRANT AGENCY AGREEMENT, dated as of ______, 2023 (“Agreement”), by and between Intelligent Bio Solutions Inc., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a Delaware limited liability company (“CST” or the “Warrant Agent”).
SERIES E COMMON STOCK PURCHASE WARRANT intelligent bio solutions INC.Intelligent Bio Solutions Inc. • September 22nd, 2023 • Surgical & medical instruments & apparatus • New York
THIS SERIES E COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date Shareholder Approval is received and effective (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five-and-a-half year anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nomi
SHARES of Common Stock _ Shares of Series E Convertible preferred stock _ SERIES E Warrants (Exerciseable for _ Shares of Common stock) AND _ SERIES F Warrants (Exerciseable for _ Shares of Common stock) of INTELLIGENT BIO SOLUTIONS INC.Underwriting Agreement • September 22nd, 2023 • Intelligent Bio Solutions Inc. • Surgical & medical instruments & apparatus • New York
The undersigned, Intelligent Bio Solutions Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Intelligent Bio Solutions Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
LEAK-OUT AGREEMENTLeak-Out Agreement • September 22nd, 2023 • Intelligent Bio Solutions Inc. • Surgical & medical instruments & apparatus
This agreement (the “Leak-Out Agreement”) is being delivered to you in connection with an understanding by and between Intelligent Bio Solutions Inc., a Delaware corporation (the “Company”), and the person or persons named on the signature pages hereto (collectively, the “Holder”).
LOCK-UP AGREEMENTLock-Up Agreement • September 22nd, 2023 • Intelligent Bio Solutions Inc. • Surgical & medical instruments & apparatus
Re: Underwriting Agreement, dated _________, 2023, by and between Intelligent Bio Solutions Inc. and Ladenburg Thalmann & Co. Inc., acting as representative to the several underwriters
DATE: _____, 2023Intelligent Bio Solutions Inc. • September 22nd, 2023 • Surgical & medical instruments & apparatus
Reference is made to that certain Underwriting Agreement, dated as of _____, 2023 (the “Underwriting Agreement”), by and between Intelligent Bio Solutions Inc. (the “Company”) and Ladenburg Thalmann & Co. Inc., as representative of the underwriters named therein (the “Representative”) which provides for the execution and delivery of this voting agreement (the “Voting Agreement”). The Underwriting Agreement relates to the public offering of the Company’s securities being conducted as set forth in the Company’s registration statement on Form S-1, as amended (Registration No. 333-273219). Capitalized terms used and not otherwise defined herein shall have the meanings set forth in the Underwriting Agreement.
